Send feedback

MOGS p.Arg613Gln

c.1838G>A · rs142032474 · VCV95358

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 11 submitters
AlphaMissense
likely benign
0.0696 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.975%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
MOGS-congenital disorder of glycosylation

Computational evidence

Protein change
AlphaMissense0.0696likely benign
REVEL0.05moderately benign-leaning
SaProtLLR -6.34tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -9.8GERP -3.4
Regional constrainto/e 0.69unconstrained · MANE · 608 bp · p 6e-07 · regional, not allelic
Overall
CADD0.091PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.975% European (non-Finnish) · 11,509/1,180,004 alleles
Filtering AF 0.96% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.954%
Overall 0.848% 13,687/1,614,114 alleles · rare exomes 12,717/1,461,830 · genomes 970/152,284 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 1.68% 60
European (non-Finnish)grpmax 0.975% 103
Remaining individualsnot grpmax-eligible 0.882% 113
Middle Eastern 0.841% 119
Admixed American 0.708% 141
Amishnot grpmax-eligible 0.439% 228
Finnishnot grpmax-eligible 0.406% 246
South Asian 0.313% 320
African / African-American 0.14% 715
East Asian 0.00223% 44,872

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MOGS
Protein
p.Arg613Gln
Coding
c.1838G>A
MANE Select
NM_006302
dbSNP
rs142032474
Type
single nucleotide variant
Location
chr2:74461951 (GRCh38)
Gene constraint
LOEUF 0.85 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 92.42
Full MOGS gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

MOGS-congenital disorder of glycosylation — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For MOGS-CDG (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mogs-p-arg613gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown